Support MS Research

Sign Up to eNewsletter

Be the first to receive the latest news on MS Research.


Increasing awareness, participation, funding and streamlining communication for MS trials.

Disappointing trial results for Gilenya in primary progressive MS

4th December, 2014

Pharmaceutical company, Novartis, has released disappointing news that Gilenya does not slow disability in a clinical trial for primary progressive MS
Read More

Participate in a survey to help understand personality, thinking and adjustment to living with MS

26th November, 2014

The aim of this study is to investigate how personality and beliefs about MS affect adjustment to MS
Read More